Emergence of dalbavancin non-susceptible, vancomycin-intermediate Staphylococcus aureus (VISA) after treatment of MRSA central line-associated bloodstream infection with a dalbavancin- and vancomycin-containing regimen

Published 2018 View Full Article

Authors

Keywords

Journal

CLINICAL MICROBIOLOGY AND INFECTION

Volume 24, Issue 4, Pages 429.e1-429.e5

Publisher

Elsevier BV

Online

2017-08-04

DOI

10.1016/j.cmi.2017.07.028

Ask authors/readers for more resources

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started

CLINICAL MICROBIOLOGY AND INFECTION

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Create your own webinar

Ask a Question. Answer a Question.